Find Clinical Trials & Studies
Ruxolitinib Cream for Prurigo Nodularis Study
I'm Interested!
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Dermatological Conditions
Study Purpose
The purpose of this study is to investigate the efficacy and safety of ruxolitinib 1.5% cream in participants with Prurigo Nodularis.
Who Can Participate
Age: 18 and older
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
- UH IRB: SITE00001987
- StudyID: 2022-01120
- ClinicalTrials.gov: NCT05755438
I'm Interested!
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422